# Christopher Shen

> Christopher Shen is a Series C investor at C-Bridge Capital backing Medical and Health Care. See 2 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [C-Bridge Capital](https://shizune.co/investors/profile/c-bridge-capital)
- Location: San Francisco, United States
- Total investments: 2
- Last investment: Mar 2025
- Lead investor: 100%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/christopher-shen-md

Christopher Shen is a Series C investor at C-Bridge Capital in San Francisco focused on Medical and Health Care. Christopher Shen serves as a Partner at Novo Holdings.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 2 | 100% |
| Health Care | 2 | 100% |
| Medical Device | 2 | 100% |
| Wearables | 1 | 50% |

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series C | 1 | 50% |
| Series E | 1 | 50% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Supira Medical | Supira Medical is a clinical-stage company that develops catheter-based circulatory support devices for patients with heart conditions. Its technology is designed to provide temporary mechanical circulatory support, aiming to improve patient outcomes during high-risk procedures or acute heart failure management. The company focuses on advancingminimally invasive solutions to enhance cardiovascular care. | $120M | Series E | Mar 26, 2025 |  |
| Element Science | Element Science is a medical device and digital health company that develops solutions at the intersection of clinical-grade wearable devices, machine learning algorithms, and lifesaving therapies to address the needs of high-risk cardiovascular patients, primarily as they transition from the hospital to home. The company developing a proprietarynext-generation wearable digital platform that unites patient-centric human factor engineering, sophisticated machine learning algorithm development principles, and rigorous electromechanical medical device development standards.The company was founded in 2011 and is headquartered in San Francisco, California. | $145.6M | Series C | Mar 03, 2020 |  |

2 of 2 investments shown.

## Co-investors
- [Cormorant Asset Management](https://shizune.co/investors/profile/cormorant-asset-management) — VC Fund, 2 deals together
- [Google Ventures](https://shizune.co/investors/profile/google-ventures) — VC Fund, 2 deals together
- [415 Capital](https://shizune.co/investors/profile/415-capital-management) — VC Fund, 1 deal together
- [AMED Ventures](https://shizune.co/investors/profile/amed-ventures) — VC Fund, 1 deal together
- [Deerfield](https://shizune.co/investors/profile/deerfield) — VC Fund, 1 deal together
- [Invus](https://shizune.co/investors/profile/invus) — VC Fund, 1 deal together

## About C-Bridge Capital

VC Fund · New York, United States

C-Bridge Capital Partners identifies and unlocks opportunities to drive growth and development across borders. They leverage their expertise in the United States, China and Israel to help their global clients form international strategic alliances that achieve maximum returns. Using their unparalleled network and extensive knowledge, Theyfacilitate cross-border investments and asset formation in the US, China and Israel. They remain involved to monitor and protect their clients’ investment interests.

5 contacts available at C-Bridge Capital.

| Name | Title | Profile |
| --- | --- | --- |
| Wei Fu | Founder & Chief Executive Officer | https://shizune.co/investors/profile/wei-fu |
| Abbas Hussain | Senior Partner | https://shizune.co/investors/profile/abbas-hussain |
| Christopher Shen | Managing Director | https://shizune.co/investors/profile/christopher-shen |
| Kang Lan | Managing Director | https://shizune.co/investors/profile/kang-lan |
| Lu Yanxiang | Senior Managing Director | https://shizune.co/investors/profile/lu-yanxiang |

## Similar investors

### Similar stage
- [Sequoia Capital](https://shizune.co/investors/profile/sequoia-capital) — VC Fund
- [New Enterprise Associates](https://shizune.co/investors/profile/new-enterprise-associates) — VC Fund
- [Bessemer Venture Partners](https://shizune.co/investors/profile/bessemer-venture-partners) — VC Fund

## FAQ

### What does Christopher Shen invest in?

Christopher Shen invests primarily in Medical, Health Care and Medical Device startups, most often at Series C and Series E stage. Most of the 2 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Christopher Shen last invest?

The most recent investment recorded for Christopher Shen closed in Mar 2025. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co